Year archive

CASI Pharmaceuticals, Inc. — 2026 filings

All 18 regulatory filings released by CASI Pharmaceuticals, Inc. (CASI) in 2026, sourced directly from the official regulator.

18 Filings

2026 Period

2026 filings (18)

Filing	Released	Lang
6-K - CASI Pharmaceuticals, Inc. (0001962738) (Filer) Foreign Filer Report	2026-04-20	English
6-K - CASI Pharmaceuticals, Inc. (0001962738) (Filer) Foreign Filer Report	2026-04-15	English
3 - CASI Pharmaceuticals, Inc. (0001962738) (Issuer) Director's Dealing	2026-03-27	English
3 - CASI Pharmaceuticals, Inc. (0001962738) (Issuer) Director's Dealing	2026-03-25	English
SCHEDULE 13D/A - CASI Pharmaceuticals, Inc. (0001962738) (Subject) Major Shareholding Notification	2026-03-23	English
3 - CASI Pharmaceuticals, Inc. (0001962738) (Issuer) Director's Dealing	2026-03-19	English
SCHEDULE 13G/A Filing Major Shareholding Notification	2026-02-17	English
SCHEDULE 13G/A Filing Major Shareholding Notification	2026-02-13	English
SCHEDULE 13D/A - CASI Pharmaceuticals, Inc. (0001962738) (Subject) Major Shareholding Notification	2026-02-10	English
6-K Filing Foreign Filer Report	2026-02-10	English
SCHEDULE 13D/A Filing Major Shareholding Notification	2026-01-29	English
Regulatory Filings 2026 Regulatory Filings	2026-01-28	English
Regulatory Filings 2026 Regulatory Filings	2026-01-28	English
FORM 6-K Foreign Filer Report	2026-01-22	English
Major Shareholding Notification 2026 Major Shareholding Notification	2026-01-20	English
Major Shareholding Notification 2026 Major Shareholding Notification	2026-01-20	English
FORM 6-K Foreign Filer Report	2026-01-13	English
Major Shareholding Notification 2026 Major Shareholding Notification	2026-01-09	English